| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Docusate sodium | Docusate Sodium Impurity C | VE009452 | View |
| Docusate sodium | Docusate Sodium Impurity D | VE009451 | View |
| Docusate sodium | Docusate Sodium Related Compound A | VL4330001 | View CAS 96954-01-7 |
| Catalogue No. | VL4330001 |
| CAS No. | 96954-01-7 |
| Molecular Formula | C12H20Na2O7S |
| Molecular Weight | 354.33 g/mol |
| Parent drug | Docusate sodium |
| IUPAC Name | sodium 4-((2-ethylhexyl)oxy)-4-oxo-2-sulfonatobutanoate |
| Synonyms | N/A |
| References | Kumar, Pandari Phani, et al. “Sulfosuccination of Methyl Ricinoleate and Methyl 12-Hydroxy Stearate Derived from Renewable Castor Oil and Evaluation of Their Surface Properties.” Journal of Surfactants and Detergents, vol. 19, no. 3, Mar. 2016, pp. 447–54, https://doi.org/10.1007/s11743-016-1804-0.?Tarumi, Yoko, et al. “Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients.” Journal of Pain and Symptom Management, vol. 45, no. 1 |
| Status | In-stock |
| ListName | Docusate Sodium Related Compound A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
